QBX258

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QBX258, covering 2016-08-01 to 2016-08-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma [Phase 2]